Recombinant 60-kda Heat Shock Protein From Paracoccidioides Brasiliensis: Is It A Good Antigen For Serological Diagnosis Of Paracoccidioidomycosis? by Peron et al.
Recombinant 60-kDa heat shock protein from
Paracoccidioides brasiliensis: is it a good antigen for
serological diagnosis of paracoccidioidomycosis?
G. Peron1, F.F. Fernandes2, T.N. Landgraf3, R. Martinez4 and A. Panunto-Castelo5
1Departamento de Biologia Estrutural e Funcional, Instituto de Biologia, Universidade Estadual de Campinas, Campinas, SP, Brasil
2Departamento de Biologia Celular e Molecular, Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo,
Ribeirão Preto, SP, Brasil
3Departamento de Bioquímica e Imunologia, Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo,
Ribeirão Preto, SP, Brasil
4Departamento de Clínica Médica, Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo,
Ribeirão Preto, SP, Brasil
5Departamento de Biologia, Faculdade de Filosofia Ciências e Letras de Ribeirão Preto, Universidade de São Paulo,
Ribeirão Preto, SP, Brasil
Abstract
Paracoccidioides brasiliensis and P. lutzii are fungi that cause paracoccidioidomycosis (PCM), the most prevalent systemic
mycosis in South America. For serological diagnosis, although 43-kDa glycoprotein (gp43) is regarded as highly specific for
PCM, the occurrence of false negative reactions in sera from patients infected with P. lutzii suggests that preparation with only
one antigen is not recommended. Heat shock proteins are feasible alternatives as a second antigen because they are often
highly immunogenic. In this study, we evaluated the usefulness of recombinant 60-kDa heat shock protein from P. brasiliensis
(rPbHsp60) for the serological diagnosis of PCM. Using western blotting assay, we observed that 77.3% of the sera from PCM
patients were positive to rPbHsp60, with 90.9% positivity to recombinant gp43 (rgp43). More importantly, sera from healthy
subjects had 27% positivity to rPbHsp60 and none to rgp43. When rPbHsp60 was used in ELISA, we did not observe significant
differences between the reactions with sera from PCM patients and healthy subjects, while the difference was clearly evident
when the antigen was rgp43. Furthermore, rPbHsp60 was recognized by sera from patients with histoplasmosis, aspergillosis,
sporotrichosis or tuberculosis in an ELISA test. These results show that rPbHsp60 is not a good antigen for PCM diagnosis.
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Introduction
The species of dimorphic fungi of the Paracoccidioides
brasiliensis complex and P. lutzii are the etiological agents
of paracoccidioidomycosis (PCM) (1), which is a human
systemic mycosis highly prevalent in South American
countries (2). Brazil has been considered one of the most
endemic areas of the world, with about 80% of all active
cases of PCM (3).
The polyclonal activation of B cells is a characteristic of
PCM that frequently results in hypergammaglobulinemia (4).
Although the protective role of antibodies in P. brasiliensis
infection is controversial, the importance of these molecules
in the diagnosis of PCM is undeniable. Moreover, serological
assays have proven helpful in clinical monitoring and follow-
up of therapy in PCM patients (5).
Many serological techniques have been widely used to
evaluate the concentration of antibodies in sera from PCM
patients, such as immunodiffusion, counterimmunoelectro-
phoresis, double immunodiffusion and immunoenzymatic
assays (reviewed in Ref. 5). In the last years, assays with
single antigens have been more often used than fungal
extract comprised of mixtures of antigens. Therefore,
many studies have sought to identify and isolate new
potential antigens from P. brasiliensis for serological tests (6).
Hitherto, the 43-kDa glycoprotein (gp43) is unambiguously
the most studied P. brasiliensis antigen. Besides being
one of the most predominant glycoproteins in P. brasi-
liensis, gp43 is recognized by most sera from PCM
patients (7).
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Because false-negative results have been reported in
assays that use gp43 (5), we speculated whether another
antigen from Paracoccidioides could be used to detect the
totality of PCM patients. Among the antigens with potential
for use in serodiagnosis of PCM, the heat shock proteins
are feasible options, since they are often highly immuno-
genic and the antibodies against them have been related
to the prognosis of many diseases (8).
In 2002, Cunha et al. (9) described a western blot assay
using recombinant heat shock protein from P. brasiliensis
(rPbHsp60) that presented high sensitivity and specificity.
They suggested that rPbHsp60 could be used as a single
antigen or in association with another one to detect spe-
cific antibodies in sera from PCM patients. Thus, in this
study, we sought to identify whether rPbHsp60 in asso-
ciation with recombinant gp43 (rgp43) could be useful
for PCM diagnosis. We have previously expressed and
purified rPbHsp60 and, here, we show the detection
of antibodies against rPbHsp60 in the sera from PCM
patients. Furthermore, we evaluated the reactivity against
rPbHsp60 of the sera from patients with other fungal
diseases and tuberculosis.
Material and Methods
Serum samples
All patient sera were obtained from the serum bank at
the Laboratório de Micologia Médica, Departamento de
Clínica Médica, Faculdade de Medicina de Ribeirão Preto,
Universidade de São Paulo. In this study, we used 22
serum samples from patients with the chronic form of
paracoccidioidomycosis (PCM), 12 with histoplasmosis (H),
12 with aspergillosis (A), 2 with sporotrichosis (S), and
8 with tuberculosis (Tb). Fifteen serum samples from
healthy volunteers (without symptoms of infection) were
tested as negative control (NC). The use of the sera
was approved by the Research Ethics Committee of the
Hospital das Clínicas, Faculdade de Medicina de Ribeirão
Preto (HCRP), Universidade de São Paulo (protocol
HCRP 13982/2005).
Expression and purification of rPbHsp60 and rgp43
Large-scale expression and purification of rPbHsp60
and rgp43 were prepared as previously described (10).
Electrophoresis and western blotting
The purified rPbHsp60 and rgp43 were applied to a
12% sodium dodecyl sulfate-polyacrylamide gel electro-
phoresis (SDS-PAGE) using a Mini Protean Tetra (Bio-Rad,
USA). The gel protein bands were stained with Coomassie
Brilliant Blue G-250 (Sigma-Aldrich, USA) or transferred to
nitrocellulose membranes (Hybond-C Extra, GE Health-
care, USA). Proteins with known molecular weights were
used as standards (LMW-SDS Marker Kit; GE Health-
care). Membranes containing 1 mg of rPbHsp60 or 1 mg of
rgp43 were blocked with 3% gelatin in Tris-buffered saline
(20 mM Tris-HCl, 150 mM NaCl, pH 7.2) containing 0.05%
of Tween-20 (TBS-T), overnight at 4°C. Then, these mem-
branes were washed three times with TBS-T and reacted
with serum samples from patients with PCM or with serum
samples from NC diluted 1:200 in a solution of 1% gelatin
in TBS-T, for 2 h at 37°C. After the incubation, the mem-
branes were washed five times and incubated with alkaline
phosphatase-conjugated goat anti-human immunoglobulin
antibody (isotyped M, G and A – whole molecule; Merck
Millipore, USA), diluted 1:10,000 in a solution of 1%
gelatin in TBS-T, for 1.5 hours at 37°C. The reaction was
developed with BCIP-NBT (5-bromo-4-chloro-3-indolyl phos-
phate and nitroblue tetrazolium; Sigma-Aldrich), according to
the manufacturer’s instructions.
ELISA
The titration of specific antibodies against rPbHsp60
and rgp43 in the sera from patients with PCM was carried
out with indirect ELISA. Sera from NC were used for con-
trol. Wells of flat-bottomed polystyrene plates (Corning,
USA) were coated with 5 mg of rPbHsp60 or rgp43 diluted
in 100 mL of 0.2 M carbonate buffer, pH 9.6, and incubated
overnight at 4°C. Then, the wells were blocked with 3%
gelatin in TBS-T for 1 h and incubated with 100 mL of
serum diluted to 1:250 in a solution of 1% of gelatin in
TBS-T, at 37°C. After 2 h, the plates were washed five
times and the wells were incubated with 100 mL of alkaline
phosphatase-conjugated goat anti-human immunoglobulin
antibody (Merck Millipore) diluted to 1:2,000, at 37°C.
After 1 hour, the wells were washed as described above
and the antigen-antibody reaction was detected with a
p-nitrophenyl phosphate (pNPP) substrate, according to
the manufacturer’s instructions (Sigma-Aldrich). The reac-
tions were done in duplicates and the absorbance was
determined at a wavelength of 405 nm. The cut-off limit
was determined by receiver-operating characteristics (ROC)
analysis and was defined as 0.68 absorbance at 405 nm.
Statistical analysis
Results are reported as the mean values of duplicates.
The non-parametric Mann-Whitney test was used to com-
pare two groups, while one-way ANOVA with the non-
parametric Kruskal-Wallis test, followed by Dunn’s multiple
comparison post test, was used to compare the difference
among multiple groups. The correlations between the
serum reactions with rgp43 and rPbHsp60 were analyzed
by means of Spearman’s correlation coefficient. Differ-
ences were considered to be statistically significant when
Po0.05. GraphPad Prism software (USA) was used for
statistical analysis. Specificity and sensitivity were ana-
lyzed by the ROC curve.
Results
To detect anti-Hsp60 and anti-gp43 antibodies in
sera from patients with PCM, we produced His-tagged
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rPbHsp60 and rgp43 in a heterologous bacterial system.
Electrophoresis analysis of these recombinant proteins
purified in a HisTrap column revealed bands with MW
about 60-kDa and 43-kDa, which is consistent with the
expected MW for rPbHsp60 and rgp43, respectively
(Figure 1).
When these recombinant proteins were used in a
western blot assay to detect specific antibodies in the sera
from PCM patients, we observed that 17 of 22 sera (77.3%)
recognized the rPbHsp60, whereas 20 of 22 (90.9%)
reacted with the rgp43 (positive control). To determine if
the serological reactions with rPbHsp60 and rgp43 were
specific, 15 NC sera were assayed, of which four (27%)
reacted with rPbHsp60 (Figure 2B and C), whereas no NC
serum was reactive to the rgp43 (Figure 2C). Only the
positive reactions were shown in Figure 2A and B.
Because the western blot tests revealed false positive
reactions, we expected and confirmed that those undesir-
able reactions with sera from NC subjects also occurred
when using ELISA, which is used to quantify the antigen-
antibody reactions. The cut-off point was established by
the ROC curve, based on the absorbance at 405 nm
obtained with sera from PCM patients and NC subjects
that were submitted to reaction with gp43. A sensitivity
of 83.3% and specificity of 100% was determined for a
cut-off point of 0.68; absorbance higher than 0.68 was
considered to be a positive result. As expected, the titers
of the sera from PCM patients with rgp43 were signifi-
cantly higher than those from NC subjects (Figure 3A) and
about 87% of the sera from PCM patients were positive for
rgp43. In contrast, many sera from the NC group, such as
PCM patient sera, had strong reactivity with rPbHsp60
(Figure 3B). In fact, the immunoassay to detected anti-
Hsp60 antibodies from sera revealed a lower specific-
ity (73.33%) and sensibility (77.27%) when compared with
anti-rgp43 detection (100 and 90.91%, respectively). Accord-
ingly, the reactions with rPbHsp60 were not significantly
different between the sera from NC subjects and PCM
patients. There also was no correlation between the
reactions obtained with rgp43 and rPbHsp60 to both PCM
patients (Figure 3D) and NC (Figure 3E) sera.
When we evaluated the reactivity of the sera from
patients with other infectious diseases with rPbHsp60 by
ELISA, we observed that most sera were positive to
rPbHsp60 (Figure 3C). In contrast, no positive reaction
was seen when these sera were assayed with rgp43 (data
not shown).
Discussion
The detection of antibodies against P. brasiliensis
antigen has been an attractive option for PCM diagnosis
and consequently one of the main diagnostic indicators of
PCM. As well as permitting rapid inference of the fungal
infection, serological diagnosis of PCM has shown to be
an important tool for monitoring the treatment of PCM
patients (6). In this research, we investigated the reactivity
of sera from patients infected with P. brasiliensis and other
pathogens, as well as healthy subjects, with the antigen
rPbHsp60 and showed the presence of a high rate of false
positive reactions.
The first aim of this study was to evaluate the use-
fulness of rPbHsp60 as an antigen for diagnosis of PCM
through western blotting assay. Although Cunha et al. (9)
have already carried out a similar study with rPbHsp60
for serology of PCM, we found quite different results.
By western blotting, they reported that 97.3% of the sera
from PCM patients and 9.52% of the normal human sera
recognized rPbHsp60, while we found 77.3 and 27%
positivity, respectively. Therefore, we obtained a lower
reaction positivity rate with sera from PCM patients and a
higher rate with serum samples from NC subjects com-
pared with the rates obtained by Cunha et al. (9). The rate
of false positivity (27%) suggests that the use of Hsp60 in
western blotting for PCM diagnosis is unfeasible.
The second aim of this study was to quantify the
antigen-antibody reactions that were initially observed in
Figure 1. Electrophoresis analysis (SDS-PAGE) of the recombi-
nant proteins gp43 and Hsp60 from P. brasiliensis. The electro-
phoretic migrations of the proteins with known molecular weights
are indicated to the left of the figure (shown in kDa). The expected
molecular weights for rPbHsp60 (B60-kDa) and rgp43 (B43-kDa)
bands were observed in the lanes 1 and 2, respectively.
Braz J Med Biol Res | doi: 10.1590/1414-431X20175928
Hsp60 from P. brasiliensis for serological diagnosis 3/6
western blotting, as well as to assess the specificity of
rPbHsp60 by ELISA. This latter technique was able to
detect high levels of P. brasiliensis antibodies in the sera
of tested PCM patients. In fact, when we evaluated the
reactivity of the sera from PCM patients or NC with rgp43
or rPbHsp60, we found no correlation between the levels
of serum antibody and the antigens. Our results also showed
that most of the tested sera from patients with other
Figure 2. Western blot analysis of the recombinant proteins from P. brasiliensis recognized by sera from patients with paracoccidioido-
mycosis (PCM) or healthy subjects (NC). Recombinant proteins were separated by SDS-PAGE and transferred to nitrocellulose
membranes. Membranes containing both proteins were incubated with sera from PCM patients (A) or NC subjects (B). After incubation
with alkaline-phosphatase-conjugated antibody to human immunoglobulin, the reactions were revealed with BCIP-NBT. The arrowheads
indicate the migration position of rPbHsp60 and rgp43. The identification of each patient serum is depicted by the numbers below each
image. The negative reaction for both proteins is not shown. C, Relative number (%) of positive reactions with serum samples from PCM
patients and NC group against rPbHsp60 and rgp43. No NC serum was reactive to rgp43.
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diseases reacted with rPbHsp60. Although these reac-
tions were probably false positive, we do not rule out that
they were due to cross-reactivity or a combination of both.
When new antigens are sought for diagnosis, the
detection of false positive reactions are cause for concern.
Even when the highly specific antigen of P. brasiliensis,
the gp43, was evaluated for the diagnosis of PCM, the
investigators found a percentage of cross-reactivity with
sera from patients with other mycosis. Although many
factors can contribute to the unspecific reactions, in this
case it became clear that the carbohydrate moiety of the
gp43 was not a species-specific glycan of P. brasiliensis
(11–13). The production of recombinant proteins can
provide potential solutions for a better diagnosis of PCM.
For the gp43, its expression in bacterial systems for
heterologous protein, which usually is non-glycosylated,
resulted in a molecule that reacted with sera from PCM
patients, but not with sera from patients with aspergillosis,
candidiasis and histoplasmosis.
In our study, the problem with cross-reactivity is prob-
ably linked to homology between the microbial Hsp60,
since the analysis of P. brasiliensis Hsp60 sequence using
Basic Local Alignment Search Tool (BLAST) revealed
93% identity with Hsp60 from Blastomyces dermatitidis
and Histoplasma capsulatum, and 89 and 81% with Hsp60
from Aspergillus fumigatus and Sporothrix schenckii,
respectively (data not shown). We do not consider the
possibility that the false positive reactions are related
to antibodies directed against the hexa-histidine tag at
C-terminus of the rPbHsp60, because no false positivity was
seen when we used rgp43, which was produced by using
the same expression vector system to produce rPbHsp60,
i.e. pET28a. Another problem found was the sensitivity
below 100% in the reactions from PCM patient sera with
gp43. We cannot exclude that some of our patients were
infected with P. lutzii, since their sera tend not to react with
gp43 (14). In fact, we did not have the identification of the
patients’ isolates in species or lineages.
Although Hsp are highly conserved molecules due to
their significant role as a chaperone on the folding and
unfolding of proteins, the rationale that initially directed our
experiments was based on the fact that the Hsp have
changed their amino acid sequences or conformational
structures during the adaptation to environmental stress
Figure 3. ELISA measurements of anti-gp43 and anti-Hsp60 antibodies from serum of patients with paracoccidioidomycosis (PCM), with
other diseases or healthy subjects (NC). Polystyrene plates were coated with (A) rgp43 or (B) rPbHsp60 and incubated with sera from
patients with PCM or NC group. C, rPbHsp60 adsorbed on polystyrene plates was also incubated with sera from patients with
histoplasmosis (His), aspergillosis (Asp), tuberculosis (Tb), and sporotrichosis (Spo). Results are reported as the mean absorbance
value (at 405 nm) of duplicated experiments. The dashed line represents the cut-off point, which was established by the ROC curve,
based on the absorbance at 405 nm obtained with sera from PCM patients and NC subjects submitted to reaction with gp43. The full line
represents the median absorbance value from each group. Comparison between groups (PCM and NC) was made by non-parametric
Mann-Whitney test. Relationship between ELISA measurements of anti-rgp43 and anti-rPbHsp60 antibodies from serum of PCM
patients (D) and NC subjects (E). There was no correlation between the results with rgp43 and rPbHsp60.
Braz J Med Biol Res | doi: 10.1590/1414-431X20175928
Hsp60 from P. brasiliensis for serological diagnosis 5/6
in evolving organisms (15). That information can be illus-
trated by the relative low identity between the amino acid
sequences of Hsp60 from P. brasiliensis and human,
which is about 55% (data not shown). Because Hsp from
microbiota can be immunogenic for the host and conse-
quently induce the production of natural or even auto-
immune antibodies, anti-Hsp antibodies can be found
under normal physiological conditions after exposure to
some environmental stress, or may be associated with
some autoimmune diseases (8).
Taken together, our results suggest that Hsp60 of
P. brasiliensis cannot be used to diagnose PCM.
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